ICON (NASDAQ:ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research organization said that it expects to report 2025 revenue of $8.05B to $8.650B ...

Based on preliminary, unaudited financial results, WidePoint (WYY) expects to exceed its full-year 2024 revenue guidance and meet or surpass ...

Northland raised the firm’s price target on Universal Technical (UTI) to $34 from $30 and keeps an Outperform rating on the shares following a ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR), a world-leading clinical research organization powered by healthcare intelligence, today announced its financial guidance for the year ending ...

(RTTNews) - ICON Plc (ICLR), healthcare intelligence and clinical research company, on Tuesday reaffirmed its annual guidance. In addition, the firm has initiated outlook for the full-year 2025.

The revised target comes in response to ICON's 2025 guidance, which Windley noted as being softer than expected. According to InvestingPro data, ICON's stock has experienced a significant 8.71% ...